Obesity Epidemic: Australian Kids Could Be Prescribed Weight Loss Drugs in Desperate Bid to Save Lives
- Australian children as young as 10 could be prescribed weight loss drugs like Wegovy in a bid to tackle the growing obesity crisis.
- Experts warn that if left unchecked, obesity could shorten the lifespan of Australian children by up to five years.
- A new international partnership between Novo Nordisk and the Murdoch Children’s Research Institute aims to explore the use of Wegovy in children living with obesity in the Pacific region.
The obesity crisis in Australia has reached alarming levels, with experts predicting that up to 75 per cent of young people in the Pacific region will be overweight or obese by 2050.
In a desperate bid to tackle the issue, pharmaceutical companies are now considering prescribing weight loss drugs like Wegovy to children as young as 10.
The proposal comes as a new three-year partnership is announced between drug maker Novo Nordisk and the Murdoch Children’s Research Institute (MCRI) to explore how Wegovy could help children living with obesity in the Pacific region.
Novo Nordisk president Mike Doustdar warned that Australia faces the same crisis, with alarming predictions for the next generation.
“A child born in Queensland today may have a lifespan of four to five years shorter than their parents because of obesity,” Doustdar said.
While urging the government to play a bigger role in helping foster healthier lifestyles, Doustdar suggested that some Australian children could benefit from the use of weight loss drugs.
Wegovy, which was initially developed as a diabetes medicine, has been shown to be effective in treating obesity. However, experts say the challenge now is ensuring equal access to the medication, which remains expensive and largely inaccessible.
Doustdar revealed that price cuts are on the table and workplaces could play a part in covering costs, citing the benefits of a healthy workforce.
Analysis: What This Means for Australia
The proposal to prescribe weight loss drugs to children has sparked concerns about the long-term effects of the medication and the need for a more holistic approach to tackling obesity.
Security analysts say that the growing obesity crisis poses a significant threat to national security, as it can lead to a range of health problems that can impact the country’s productivity and economy.
Law enforcement insiders warn that the crisis also has implications for community safety, as obesity can contribute to a range of social problems.
Industry observers believe that the government needs to take a more proactive role in addressing the root causes of obesity, including the lack of access to healthy food and exercise opportunities in disadvantaged communities.
They also suggest that workplaces can play a part in promoting healthy lifestyles, by providing access to healthy food options and exercise facilities.
While the proposal to prescribe weight loss drugs to children is a controversial one, experts agree that something needs to be done to address the growing obesity crisis.
As the Pacific region grapples with the challenge of tackling obesity, Australia must also take a hard look at its own approach to addressing the issue and consider the long-term implications for the health and wellbeing of its citizens.
